Trends and Opportunities in Pediatric Drug Development
Posted on April 10, 2015
By: Daniel E. Schaufelberger, Ph.D., Scientific Director and CMC Leader
Janssen Research & Development L.L.C
Introduction Children are not just small adults: their bodies, physiology and metabolism change as they grow from birth to adulthood. Many well-characterised adult diseases have different etiology and manifestation in children and require tailored approaches to successful treatment. Furthermore, any...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
acceptability, age-appropriate, assessed., Daniel E. Schaufelberger, efficacy, European Union, health authorities, Janssen Research & Development L.L.C, Opportunities, Pediatric Drug Development, pediatric formulations, pediatric product development, safety, specifically designed, tailored approaches, Trends, US
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
